VitaNova Life Sciences (VNOV) EBIT Growth (5y) (2022 - 2026)
VitaNova Life Sciences (VNOV) EBIT Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 78.50% |
| Oct 31, 2025 | 58.51% |
| Jul 31, 2025 | -23.60% |
| Apr 30, 2025 | 112.27% |
| Jan 31, 2025 | 79.26% |
| Oct 31, 2024 | 39.10% |
| Jul 31, 2024 | -9.91% |
| Apr 30, 2024 | 45.87% |
| Jan 31, 2024 | 16.67% |
| Oct 31, 2023 | -1.67% |
| Jul 31, 2023 | -36.24% |
| Oct 31, 2022 | -14.76% |
| Jul 31, 2022 | -36.96% |